JPWO2021099531A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021099531A5
JPWO2021099531A5 JP2022529813A JP2022529813A JPWO2021099531A5 JP WO2021099531 A5 JPWO2021099531 A5 JP WO2021099531A5 JP 2022529813 A JP2022529813 A JP 2022529813A JP 2022529813 A JP2022529813 A JP 2022529813A JP WO2021099531 A5 JPWO2021099531 A5 JP WO2021099531A5
Authority
JP
Japan
Prior art keywords
orally disintegrating
months
disintegration
tablet according
zonisamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022529813A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502738A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/082809 external-priority patent/WO2021099531A1/fr
Publication of JP2023502738A publication Critical patent/JP2023502738A/ja
Publication of JPWO2021099531A5 publication Critical patent/JPWO2021099531A5/ja
Pending legal-status Critical Current

Links

JP2022529813A 2019-11-22 2020-11-20 ゾニサミド口腔分散性錠剤 Pending JP2023502738A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19383034.6 2019-11-22
EP19383034 2019-11-22
PCT/EP2020/082809 WO2021099531A1 (fr) 2019-11-22 2020-11-20 Comprimés orodispersibles de zonisamide

Publications (2)

Publication Number Publication Date
JP2023502738A JP2023502738A (ja) 2023-01-25
JPWO2021099531A5 true JPWO2021099531A5 (fr) 2023-11-08

Family

ID=68808236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022529813A Pending JP2023502738A (ja) 2019-11-22 2020-11-20 ゾニサミド口腔分散性錠剤

Country Status (5)

Country Link
EP (1) EP4061328B1 (fr)
JP (1) JP2023502738A (fr)
ES (1) ES2976470T3 (fr)
PT (1) PT4061328T (fr)
WO (1) WO2021099531A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2393640T3 (es) * 2008-02-13 2012-12-26 Dainippon Sumitomo Pharma Co., Ltd. Comprimidos bucodisgregables
US10292934B2 (en) 2012-09-20 2019-05-21 Daicel Corporation Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition

Similar Documents

Publication Publication Date Title
JP6162196B2 (ja) 遅延性持続ドラッグデリバリー
JP6162197B2 (ja) 即時／遅延ドラッグデリバリー
JP2015091822A5 (fr)
JP2011500583A5 (fr)
TWI491395B (zh) 一種內含用以治療神經退化性疾病之立即釋出與長效釋出藥物的口服劑量配方
JPH05213741A (ja) デプレニル／ｌ−ドーパ／カルビドーパ含有の医薬組成物
JP2018118966A5 (fr)
CA3157788A1 (fr) Composition pharmaceutique orale comprenant un compose carbamate et procede de preparation de cette composition
JP2019019113A (ja) メマンチン塩酸塩含有口腔内崩壊錠
EP3813822A2 (fr) Compositions pharmaceutiques solides d'administration par voie orale comprenant du tériflunomide
JP6366794B2 (ja) 原薬の化学的安定性や服用感を向上した、口腔内崩壊錠
WO2013109225A1 (fr) Formulations pharmaceutiques en comprimés comprenant du ceftibutène
JPWO2021099531A5 (fr)
WO2012080703A1 (fr) Composition pharmaceutique comprenant de l'imatinib
JP2019052147A (ja) 化学的な安定性が改善された、プレガバリン含有口腔内崩壊錠
JP2022046737A (ja) 安定性及び溶出率が改善されたタダラフィル含有及びタムスロシン含有のカプセル複合製剤
JP2018118909A (ja) プレガバリン含有医薬組成物
KR20130023127A (ko) 프레가발린을 포함하는 서방성 제제
JP2019182859A (ja) 口腔内崩壊錠
JP2018172361A (ja) 光安定性を改善した、デュロキセチンを含有する固形製剤
JP7423297B2 (ja) 口腔内崩壊錠およびその製造方法
JP6858873B2 (ja) セレコキシブを含む錠剤
JP6336651B1 (ja) 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤
JP2016138073A (ja) 安定性を改善した、シロドシンを含有する錠剤
WO2013180675A1 (fr) Formulation en comprimés comprenant de la dapoxétine